vs
Apellis Pharmaceuticals, Inc.（APLS）与Teads Holding Co.（TEAD）财务数据对比。点击上方公司名可切换其他公司
Teads Holding Co.的季度营收约是Apellis Pharmaceuticals, Inc.的1.8倍（$352.2M vs $199.9M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -121.6%，领先92.1%），Teads Holding Co.同比增速更快（50.2% vs -5.9%），Teads Holding Co.自由现金流更多（$6.5M vs $-14.3M），过去两年Teads Holding Co.的营收复合增速更高（27.4% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Teads Holding Co.是全球领先的端到端数字视频广告平台运营商，与优质网络出版商及品牌广告主合作，在桌面端、移动端及联网电视设备投放定制化视频广告，服务覆盖全球主要市场，核心业务为面向数字营销领域的程序化广告技术解决方案。
APLS vs TEAD — 直观对比
营收规模更大
TEAD
是对方的1.8倍
$199.9M
营收增速更快
TEAD
高出56.1%
-5.9%
净利率更高
APLS
高出92.1%
-121.6%
自由现金流更多
TEAD
多$20.8M
$-14.3M
两年增速更快
TEAD
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $352.2M |
| 净利润 | $-59.0M | $-428.2M |
| 毛利率 | — | 34.2% |
| 营业利润率 | -25.6% | -98.2% |
| 净利率 | -29.5% | -121.6% |
| 营收同比 | -5.9% | 50.2% |
| 净利润同比 | -62.2% | -256321.6% |
| 每股收益（稀释后） | $-0.40 | $-4.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSTEAD
| Q4 25 | $199.9M | $352.2M | ||
| Q3 25 | $458.6M | $318.8M | ||
| Q2 25 | $178.5M | $343.1M | ||
| Q1 25 | $166.8M | $286.4M | ||
| Q4 24 | $212.5M | $234.6M | ||
| Q3 24 | $196.8M | $224.2M | ||
| Q2 24 | $199.7M | $214.1M | ||
| Q1 24 | $172.3M | $217.0M |
净利润APLSTEAD
| Q4 25 | $-59.0M | $-428.2M | ||
| Q3 25 | $215.7M | $-19.7M | ||
| Q2 25 | $-42.2M | $-14.3M | ||
| Q1 25 | $-92.2M | $-54.8M | ||
| Q4 24 | $-36.4M | $-167.0K | ||
| Q3 24 | $-57.4M | $6.7M | ||
| Q2 24 | $-37.7M | $-2.2M | ||
| Q1 24 | $-66.4M | $-5.0M |
毛利率APLSTEAD
| Q4 25 | — | 34.2% | ||
| Q3 25 | — | 33.2% | ||
| Q2 25 | — | 35.1% | ||
| Q1 25 | — | 28.9% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 19.2% |
营业利润率APLSTEAD
| Q4 25 | -25.6% | -98.2% | ||
| Q3 25 | 48.7% | -2.0% | ||
| Q2 25 | -18.6% | -0.7% | ||
| Q1 25 | -50.0% | -15.5% | ||
| Q4 24 | -12.3% | 1.1% | ||
| Q3 24 | -24.0% | -1.3% | ||
| Q2 24 | -14.7% | -2.6% | ||
| Q1 24 | -36.0% | -3.0% |
净利率APLSTEAD
| Q4 25 | -29.5% | -121.6% | ||
| Q3 25 | 47.0% | -6.2% | ||
| Q2 25 | -23.6% | -4.2% | ||
| Q1 25 | -55.3% | -19.2% | ||
| Q4 24 | -17.1% | -0.1% | ||
| Q3 24 | -29.2% | 3.0% | ||
| Q2 24 | -18.9% | -1.0% | ||
| Q1 24 | -38.5% | -2.3% |
每股收益（稀释后）APLSTEAD
| Q4 25 | $-0.40 | $-4.63 | ||
| Q3 25 | $1.67 | $-0.21 | ||
| Q2 25 | $-0.33 | $-0.15 | ||
| Q1 25 | $-0.74 | $-0.70 | ||
| Q4 24 | $-0.30 | $0.02 | ||
| Q3 24 | $-0.46 | $0.01 | ||
| Q2 24 | $-0.30 | $-0.04 | ||
| Q1 24 | $-0.54 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $138.7M |
| 总债务越低越好 | — | $605.1M |
| 股东权益账面价值 | $370.1M | $95.4M |
| 总资产 | $1.1B | $1.3B |
| 负债/权益比越低杠杆越低 | — | 6.34× |
8季度趋势，按日历期对齐
现金及短期投资APLSTEAD
| Q4 25 | $466.2M | $138.7M | ||
| Q3 25 | $479.2M | $138.3M | ||
| Q2 25 | $370.0M | $166.1M | ||
| Q1 25 | $358.4M | $155.9M | ||
| Q4 24 | $411.3M | $166.1M | ||
| Q3 24 | $396.9M | $130.5M | ||
| Q2 24 | $360.1M | $162.7M | ||
| Q1 24 | $325.9M | $163.3M |
总债务APLSTEAD
| Q4 25 | — | $605.1M | ||
| Q3 25 | — | $604.0M | ||
| Q2 25 | — | $603.0M | ||
| Q1 25 | — | $610.8M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | $93.1M | $118.0M |
股东权益APLSTEAD
| Q4 25 | $370.1M | $95.4M | ||
| Q3 25 | $401.2M | $519.3M | ||
| Q2 25 | $156.3M | $532.0M | ||
| Q1 25 | $164.2M | $474.7M | ||
| Q4 24 | $228.5M | $231.3M | ||
| Q3 24 | $237.1M | $227.2M | ||
| Q2 24 | $264.3M | $216.0M | ||
| Q1 24 | $266.7M | $216.9M |
总资产APLSTEAD
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $821.4M | $1.8B | ||
| Q1 25 | $807.3M | $1.7B | ||
| Q4 24 | $885.1M | $549.2M | ||
| Q3 24 | $901.9M | $530.1M | ||
| Q2 24 | $904.5M | $626.2M | ||
| Q1 24 | $831.9M | $626.7M |
负债/权益比APLSTEAD
| Q4 25 | — | 6.34× | ||
| Q3 25 | — | 1.16× | ||
| Q2 25 | — | 1.13× | ||
| Q1 25 | — | 1.29× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.55× | ||
| Q1 24 | 0.35× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $7.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $6.5M |
| 自由现金流率自由现金流/营收 | -7.1% | 1.8% |
| 资本支出强度资本支出/营收 | 0.1% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $2.0M |
8季度趋势，按日历期对齐
经营现金流APLSTEAD
| Q4 25 | $-14.2M | $7.3M | ||
| Q3 25 | $108.5M | $-23.7M | ||
| Q2 25 | $4.4M | $25.0M | ||
| Q1 25 | $-53.4M | $-966.0K | ||
| Q4 24 | $19.4M | $42.7M | ||
| Q3 24 | $34.1M | $13.7M | ||
| Q2 24 | $-8.3M | $3.6M | ||
| Q1 24 | $-133.0M | $8.6M |
自由现金流APLSTEAD
| Q4 25 | $-14.3M | $6.5M | ||
| Q3 25 | $108.3M | $-24.5M | ||
| Q2 25 | $4.4M | $23.9M | ||
| Q1 25 | $-53.4M | $-3.9M | ||
| Q4 24 | $19.3M | $40.0M | ||
| Q3 24 | — | $11.1M | ||
| Q2 24 | $-8.4M | $2.8M | ||
| Q1 24 | $-133.3M | $7.3M |
自由现金流率APLSTEAD
| Q4 25 | -7.1% | 1.8% | ||
| Q3 25 | 23.6% | -7.7% | ||
| Q2 25 | 2.5% | 7.0% | ||
| Q1 25 | -32.0% | -1.4% | ||
| Q4 24 | 9.1% | 17.0% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | -4.2% | 1.3% | ||
| Q1 24 | -77.3% | 3.4% |
资本支出强度APLSTEAD
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.2% | 0.6% |
现金转化率APLSTEAD
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
TEAD
暂无分部数据
